152
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital

, , &
Pages 527-531 | Received 04 Jul 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Thomas M. Baker & Michael J. Satlin. (2016) The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies. Leukemia & Lymphoma 57:10, pages 2245-2258.
Read now
Matthew E Falagas, Antonia C Kastoris, Evridiki K Vouloumanou, Petros I Rafailidis, Anastasios M Kapaskelis & George Dimopoulos. (2009) Attributable Mortality of Stenotrophomonas Maltophilia Infections: A Systematic Review of the Literature. Future Microbiology 4:9, pages 1103-1109.
Read now
Katsuhiko Hiromura, Madoka Furuhashi, Kojiro Minami, Ken Miyazaki, Kana Yoshida, Naohiko Kuno & Kaoru Ishikawa. (2007) Life-threatening septic shock in a pregnant woman with ileus. The Journal of Maternal-Fetal & Neonatal Medicine 20:6, pages 491-493.
Read now

Articles from other publishers (37)

Shinichi Morimoto, Kentaro Muranishi, Yoshito Izutani, Junichi Maruyama, Reijiro Kato, Shun Ninomiya, Yoshihiko Nakamura, Taisuke Kitamura, Tohru Takata & Hiroyasu Ishikura. (2024) Assessment of the prognosis, frequency, and isolated bacteria in ventilator-associated pneumonia among patients with severe coronavirus disease 2019 pneumonia: A single-center retrospective observational study. Journal of Infection and Chemotherapy 30:6, pages 499-503.
Crossref
Wasim S. El Nekidy, Khaled Al Zaman, Emna Abidi, Diaa Alrahmany, Islam M. Ghazi, Rania El Lababidi, Mohamad Mooty, Fadi Hijazi, Muriel Ghosn, Mohamed Askalany, Mohamed Helal, Ahmed Taha, Khaled Ismail & Jihad Mallat. (2024) Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies. Journal of Clinical Medicine 13:8, pages 2275.
Crossref
Morgan L. Bixby, Dina Zheng & Elizabeth B. Hirsch. (2024) Long Story Short: Establishing Breakpoints for Antimicrobials and 2023 Updates. Current Infectious Disease Reports 26:2, pages 47-55.
Crossref
Chienhsiu Huang, Sufang Kuo & Lichen Lin. (2024) Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia in Patients with Hematologic Malignancies—A Systematic Review and Meta-Analysis. Medicina 60:1, pages 162.
Crossref
Bibin Scaria, Pavan Chand Kumar, Beena Antony & Sashidhar Kotian. (2023) Stenotrophomonas Maltophilia in Blood Stream Infections – An Overview. European Journal of Medical and Health Sciences 5:4, pages 13-17.
Crossref
Nimet Melis Bilen, Zumrut Sahbudak Bal, Gizem Güner Özenen, Sema Yildirim Arslan, Gulcihan Ozek, Nihal Ozdemir Karadas, Pinar Yazici, Feriha CilliZafer Kurugöl. (2023) Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections. Pediatric Infectious Disease Journal 42:5, pages 374-380.
Crossref
Maria F. Mojica, Romney Humphries, John J. Lipuma, Amy J. Mathers, Gauri G. Rao, Samuel A. Shelburne, Derrick E. Fouts, David Van Duin & Robert A. Bonomo. (2022) Clinical challenges treating Stenotrophomonas maltophilia infections: an update . JAC-Antimicrobial Resistance 4:3.
Crossref
Tekin Tuncel, Halis Akalın, Melda Payaslıoğlu, Emel Yılmaz, Esra Kazak, Yasemin Heper & Cüneyt Özakın. (2021) Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome. Cureus.
Crossref
Stefan K. Zöllner, Stefanie Kampmeier, Neele J. Froböse, Heidrun Herbrüggen, Katja Masjosthusmann, Alijda van den Heuvel, Christian Reicherts, Andreas Ranft & Andreas H. Groll. (2021) Stenotrophomonas maltophilia Infections in Pediatric Patients – Experience at a European Center for Pediatric Hematology and Oncology. Frontiers in Oncology 11.
Crossref
Sara M. Karaba, Katherine E. Goodman, Joe Amoah, Sara E. Cosgrove & Pranita D. Tamma. (2021) StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population. Antimicrobial Agents and Chemotherapy 65:8.
Crossref
W. Imoto, K. Yamada, G. Kuwabara, K. Yamairi, W. Shibata, K. Oshima, K. Nakaie, T. Watanabe, K. Asai, Y. Kaneko, T. Kawaguchi & H. Kakeya. (2021) In which cases of pneumonia should we consider treatments for Stenotrophomonas maltophilia?. Journal of Hospital Infection 111, pages 169-175.
Crossref
Zeynep Gökçe Gayretli Aydιn, Gonul Tanir, Gulsum Iclal Bayhan, Turkan Aydin Teke, Ozge Metin AkçanAyse Kaman, Sevgi Yasar Durmus & Fatma Nur Oz. (2020) Risk Factors of Stenotrophomonas maltophilia Blood Stream Infections: Comparison With Other Gram-Negative Blood Stream Infections in Children. Pediatric Infectious Disease Journal 39:12, pages e406-e409.
Crossref
Waki Imoto, Koichi Yamada, Kazushi Yamairi, Wataru Shibata, Hiroki Namikawa, Satomi Yukawa, Naoko Yoshii, Kiyotaka Nakaie, Asao Hirose, Hideo Koh, Tetsuya Watanabe, Kazuhisa Asai, Hirohisa Nakamae, Yukihiro Kaneko, Tomoya Kawaguchi, Masayuki Hino & Hiroshi Kakeya. (2020) Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i>. Internal Medicine 59:2, pages 193-198.
Crossref
Philippe Guerci, Hugo Bellut, Mokhtar Mokhtari, Julie Gaudefroy, Nicolas Mongardon, Claire Charpentier, Guillaume Louis, Parvine Tashk, Clément Dubost, Stanislas Ledochowski, Antoine Kimmoun, Thomas Godet, Julien Pottecher, Jean-Marc Lalot, Emmanuel Novy, David Hajage & Adrien Bouglé. (2019) Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study. Critical Care 23:1.
Crossref
J.-H. Ko, C.-I. Kang, P. Cornejo-Juárez, K.-M. Yeh, C.-H. Wang, S.Y. Cho, M.G. Gözel, S.-H. Kim, P.-R. Hsueh, N. Sekiya, Y. Matsumura, D.-G. Lee, S.-Y. Cho, S. Shiratori, Y.-J. Kim, D.R. Chung & K.R. Peck. (2019) Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clinical Microbiology and Infection 25:5, pages 546-554.
Crossref
Guangyang Xu, Xueping Tang, Xueyi Shang, Yan Li, Jing Wang, Junjie Yue & Yan Li. (2018) Identification of immunogenic outer membrane proteins and evaluation of their protective efficacy against Stenotrophomonas maltophilia. BMC Infectious Diseases 18:1.
Crossref
A. Inviati, D.M. Pellegrino & D. Schifano. (2018) Severe hepatic abscess: Conservative treatment of multi-organ infection by Stenotrophomonas maltophilia. A case report. Annals of Medicine and Surgery 34, pages 62-65.
Crossref
Si-Ho Kim, Sun Young Cho, Cheol-In Kang, Hyeri Seok, Kyungmin Huh, Young Eun Ha, Doo Ryeon Chung, Nam Yong Lee, Kyong Ran Peck & Jae-Hoon Song. (2017) Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy. Annals of Hematology 97:2, pages 343-350.
Crossref
Hirotaka Ebara, Hideharu Hagiya, Yuto Haruki, Eisei Kondo & Fumio Otsuka. (2017) Clinical Characteristics of <i>Stenotrophomonas maltophilia</i> Bacteremia: A Regional Report and a Review of a Japanese Case Series. Internal Medicine 56:2, pages 137-142.
Crossref
Kosuke Sumida, Yong Chong, Noriko Miyake, Tomohiko Akahoshi, Mitsuhiro Yasuda, Nobuyuki Shimono, Shinji Shimoda, Yoshihiko Maehara & Koichi Akashi. (2015) Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study. PLOS ONE 10:7, pages e0133731.
Crossref
Go Hotta, Yasufumi Matsumura, Karin Kato, Satoshi Nakano, Tomoyuki Yunoki, Masaki Yamamoto, Miki Nagao, Yutaka Ito, Shunji Takakura & Satoshi Ichiyama. (2014) Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species. PLoS ONE 9:11, pages e112208.
Crossref
Souichi Shiratori, Kentaro Wakasa, Kohei Okada, Junichi Sugita, Koji Akizawa, Akio Shigematsu, Daigo Hashimoto, Katsuya Fujimoto, Tomoyuki Endo, Takeshi Kondo, Chikara Shimizu, Satoshi Hashino & Takanori Teshima. (2014) Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single‐center experience . Clinical Transplantation 28:6, pages 656-661.
Crossref
Hideharu Hagiya, Hiroko Ogawa, Tomoharu Ishida, Tomohiro Terasaka, Kosuke Kimura, Koichi Waseda, Yoshihisa Hanayama, Masahiro Horita, Yasunori Shimamura, Eisei Kondo & Fumio Otsuka. (2014) Recurrent <i>Stenotrophomonas maltophilia</i> Bacteremia after Iliac Crest Bone Graft Harvest. Internal Medicine 53:15, pages 1693-1698.
Crossref
Yu Lin Wang, Marco R. Scipione, Yanina Dubrovskaya & John Papadopoulos. (2014) Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections. Antimicrobial Agents and Chemotherapy 58:1, pages 176-182.
Crossref
Hayati Demiraslan, Mustafa Sevim, Çiğdem Pala, Süleyman Durmaz, Veli Berk, Leylagül Kaynar & Gökhan Metan. (2013) Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology–oncology patients. International Journal of Hematology 97:3, pages 414-420.
Crossref
Gou HOTTA, Yasufumi MATSUMURA, Karin KATO, Satoshi NAKANO, Tomoyuki YUNOKI, Masaki YAMAMOTO,, Miki NAGAO, Yutaka ITO, Shunji TAKAKURA & Satoshi ICHIYAMA. (2013) Risk Factors and Clinical Charasteristics of <i>Stenotrophomonas maltophilia</i> Bacteremia : A Comparison with Bacteremia Due to Other Glucose-non Fermenters. Kansenshogaku Zasshi 87:5, pages 596-602.
Crossref
K Tada, S Kurosawa, N Hiramoto, K Okinaka, N Ueno, Y Asakura, S-W Kim, T Yamashita, S-I Mori, Y Heike, A M Maeshima, R Tanosaki, K Tobinai & T Fukuda. (2012) Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplantation 48:1, pages 74-79.
Crossref
M. Garazi, C. Singer, J. Tai & C.C. Ginocchio. (2012) Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. Journal of Hospital Infection 81:2, pages 114-118.
Crossref
Joanna S. Brooke. (2012) Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen. Clinical Microbiology Reviews 25:1, pages 2-41.
Crossref
Un-In Wu, Wan-Chin Chen, Ching-Shiang Yang, Jiun-Ling Wang, Fu-Chang Hu, Shan-Chwen Chang & Yee-Chun Chen. (2012) Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis. International Journal of Infectious Diseases 16:1, pages e47-e52.
Crossref
M. N. AL-HASAN, J. E. ECKEL-PASSOW & L. M. BADDOUR. (2011) Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiology and Infection 139:11, pages 1750-1756.
Crossref
Hsin-Yun Sun, Wen-Je Ko, Pi-Ru Tsai, Chun-Chuan Sun, Yin-Yin Chang, Ching-Wen Lee & Yee-Chun Chen. (2010) Infections occurring during extracorporeal membrane oxygenation use in adult patients. The Journal of Thoracic and Cardiovascular Surgery 140:5, pages 1125-1132.e2.
Crossref
W John Looney, Masashi Narita & Kathrin Mühlemann. (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. The Lancet Infectious Diseases 9:5, pages 312-323.
Crossref
Carlos A. Sattler. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases 1669 1673 .
Jorge G. Paez, Anna S. Levin, Mariusa Basso, Laura B. Gomez, Satiko Gobara, Fernanda Spadão, Isabel Oshiro & Silvia Figueiredo Costa. (2015) Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years . Infection Control & Hospital Epidemiology 29:10, pages 989-990.
Crossref
J.I. Garcia Paez & S.F. Costa. (2008) Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. Journal of Hospital Infection 70:2, pages 101-108.
Crossref
P. Rocco LaSala, Jonathan Segal, Faye S. Han, Jeffrey J. Tarrand & Xiang Y. Han. (2007) First Reported Infections Caused by Three Newly Described Genera in the Family Xanthomonadaceae . Journal of Clinical Microbiology 45:2, pages 641-644.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.